Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian N Fleming

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Hypoxia (Auckland, N.Z.)|June 6, 2017
KEMTUB012-NI2, a novel potent tubulysin analog that selectively targets hypoxic cancer cells and is potentiated by cytochrome p450 reductase downregulationPaolo Lazzari, Marco Spiga, Monica Sani, et al.
Journal of Cancer Research and Clinical Oncology|January 31, 2015
The tubulysin analogue KEMTUB10 induces apoptosis in breast cancer cells via p53, Bim and Bcl-2Oluwafunmilayo F Lamidi, Monica Sani, Paolo Lazzari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2008
Synergistic inhibition of ErbB signaling by combined treatment with seliciclib and ErbB-targeting agentsIan N Fleming, Morag Hogben, Sheelagh Frame, et al.
Molecular Imaging and Biology|July 12, 2017
Binding of α<sub>v</sub>β<sub>3</sub> Integrin-Specific Radiotracers Is Modulated by Both Integrin Expression Level and Activation StatusAlexandra Andriu, Julie Crockett, Sergio Dall'Angelo, et al.
Journal of Cancer Research and Clinical Oncology|January 13, 2015
Changes in [18F]Fluoro-2-deoxy-D-glucose incorporation induced by doxorubicin and anti-HER antibodies by breast cancer cells modulated by co-treatment with metformin and its effects on intracellular signallingAlasdair C Cooper, Ian N Fleming, Su M Phyu, et al.
Scientific Reports|November 5, 2016
Probing the PI3K/Akt/mTor pathway using <sup>31</sup>P-NMR spectroscopy: routes to glycogen synthase kinase 3Su M Phyu, Chih-Chung Tseng, Ian N Fleming, et al.
Annals of Clinical and Translational Neurology|August 14, 2020
Widespread tissue hypoxia dysregulates cell and metabolic pathways in SMAElena Hernandez-Gerez, Sergio Dall'Angelo, Jon M Collinson, et al.
Organic & Biomolecular Chemistry|January 26, 2019
Enzymatic radiosynthesis of a <sup>18</sup>F-Glu-Ureido-Lys ligand for the prostate-specific membrane antigen (PSMA)Phillip T Lowe, Sergio Dall'Angelo, Ian N Fleming, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 5, 2016
Last-Step Enzymatic [(18) F]-Fluorination of Cysteine-Tethered RGD Peptides Using Modified Barbas LinkersQingzhi Zhang, Sergio Dall'Angelo, Ian N Fleming, et al.
The Biochemical Journal|April 20, 2002
Subcellular localization of phosphatidylinositol 4,5-bisphosphate using the pleckstrin homology domain of phospholipase C delta1Stephen A Watt, Gursant Kular, Ian N Fleming, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Hypoxia (Auckland, N.Z.)|June 6, 2017
KEMTUB012-NI2, a novel potent tubulysin analog that selectively targets hypoxic cancer cells and is potentiated by cytochrome p450 reductase downregulationPaolo Lazzari, Marco Spiga, Monica Sani, et al.
Journal of Cancer Research and Clinical Oncology|January 31, 2015
The tubulysin analogue KEMTUB10 induces apoptosis in breast cancer cells via p53, Bim and Bcl-2Oluwafunmilayo F Lamidi, Monica Sani, Paolo Lazzari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2008
Synergistic inhibition of ErbB signaling by combined treatment with seliciclib and ErbB-targeting agentsIan N Fleming, Morag Hogben, Sheelagh Frame, et al.
Molecular Imaging and Biology|July 12, 2017
Binding of α<sub>v</sub>β<sub>3</sub> Integrin-Specific Radiotracers Is Modulated by Both Integrin Expression Level and Activation StatusAlexandra Andriu, Julie Crockett, Sergio Dall'Angelo, et al.
Journal of Cancer Research and Clinical Oncology|January 13, 2015
Changes in [18F]Fluoro-2-deoxy-D-glucose incorporation induced by doxorubicin and anti-HER antibodies by breast cancer cells modulated by co-treatment with metformin and its effects on intracellular signallingAlasdair C Cooper, Ian N Fleming, Su M Phyu, et al.
Scientific Reports|November 5, 2016
Probing the PI3K/Akt/mTor pathway using <sup>31</sup>P-NMR spectroscopy: routes to glycogen synthase kinase 3Su M Phyu, Chih-Chung Tseng, Ian N Fleming, et al.
Annals of Clinical and Translational Neurology|August 14, 2020
Widespread tissue hypoxia dysregulates cell and metabolic pathways in SMAElena Hernandez-Gerez, Sergio Dall'Angelo, Jon M Collinson, et al.
Organic & Biomolecular Chemistry|January 26, 2019
Enzymatic radiosynthesis of a <sup>18</sup>F-Glu-Ureido-Lys ligand for the prostate-specific membrane antigen (PSMA)Phillip T Lowe, Sergio Dall'Angelo, Ian N Fleming, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 5, 2016
Last-Step Enzymatic [(18) F]-Fluorination of Cysteine-Tethered RGD Peptides Using Modified Barbas LinkersQingzhi Zhang, Sergio Dall'Angelo, Ian N Fleming, et al.
The Biochemical Journal|April 20, 2002
Subcellular localization of phosphatidylinositol 4,5-bisphosphate using the pleckstrin homology domain of phospholipase C delta1Stephen A Watt, Gursant Kular, Ian N Fleming, et al.
Pageof 3